Institut Català de la Salut - ICS: Recent submissions
Ara mostrant els elements 66-70 d 5735
-
IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors
(American Association for Cancer Research, 2025-09)



